- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Emcure Pharmaceuticals Limited — Updates, 23-12-2025: General Updates
23-12-2025 | 06:12 pm
23-12-2025 | 06:12 pm
Emcure's Kadu manufacturing facility received a "No Action Indicated" (NAI) classification from the US FDA after its inspection. This positive development signals compliance and clears a key operational hurdle, benefiting its US market operations.
No comments yet. Be the first to comment!